https://www.techtransfer.nih.gov/patent/e-136-2018-1-tr-26
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab | Technology Transfer
https://pubmed.ncbi.nlm.nih.gov/32444417/
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib...
This is currently the largest post-PARPi study identifying genomic mechanisms of resistance to PARPis. In this setting, the activity of cediranib-olaparib...
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-cediranib-advanced-cervical-cancer
A trial looking at cediranib and chemotherapy for advanced cervical cancer (CIRCCa)
This trial looked at 2 chemotherapy drugs called carboplatin and paclitaxel alongside another drug called cediranib for cervical cancer.
looking at
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-cediranib-people-advanced-biliary-tract-cancers-abc03
A trial looking at cediranib for people with advanced biliary tract cancers (ABC 03)
This trial compared a combination of chemotherapy and a drug called cediranib with chemotherapy alone for cancer of the biliary tract.
https://profiles.wustl.edu/en/publications/rapid-development-of-hypertension-and-proteinuria-with-cediranib-/fingerprints/?sortBy=alphabetically
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial...
rapid development
https://www.techtransfer.nih.gov/patent/e-136-2018-1-au-02
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB | Technology Transfer
methodsfixedintermittentdosingtechnology
https://www.techtransfer.nih.gov/patent/e-136-2018-1-de-16
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab | Technology Transfer
https://www.techtransfer.nih.gov/patent/e-136-2018-1-hu-19
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab | Technology Transfer